SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure as traders react to the boards investigation into Jensen Huangs admitted affair with a businesswoman reported to have suspected ties to Chinese intelligence, raising concerns about governance, possible information leaks, and Huangs future as CEO. The community is divided between seeing the probe and leadership uncertainty as a serious overhang and treating the controversy as unrelated to Nvidias AI-chip business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is under heavy selling pressure ahead of its Q3 earnings report, with traders speculating about a possible leak while others see the decline as pre-report positioning; a leak is unconfirmed. Bulls point to growth and potential upbeat guidance, while bears worry that the Eli Lilly obesity-drug deal could pressure margins and profitability.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing attention after Oppenheimer upgraded the stock, while Google Clouds use of EPYC processors in its AI infrastructure added a company-specific catalyst. Traders also point to money rotating from Nvidia amid a CEO-related investigation, though some see the move as sentiment-driven and question AMDs valuation.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are rallying sharply ahead of its Q3 earnings report, with traders speculating about short covering and an earnings leak, though neither explanation is confirmed. The move has fueled hopes for a turnaround, while many investors worry that weak results or guidance could erase the gains.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Post-merger selling in Agility Robotics is drawing attention, with traders pointing to typical de-SPAC volatility and questioning the companys steep losses, limited revenue, and path to commercial scale. Some remain bullish on humanoid robotics and the companys reported orders, but the discussion is dominated by skepticism about valuation and near-term execution.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy, focused on the amended upper-limb-function evidence from HOPE-3, is driving attention ahead of the Nov. 22 PDUFA date. Bulls cite the trial data and a letter urging approval from 28 investigators, while skeptics point to FDA scrutiny and the earlier negative advisory-panel vote on the cardiac indication; short-squeeze speculation adds to the debate.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Earnings Estimates Moving Higher for The RealReal (REAL): Time to Buy?

The RealReal (REAL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

The RealReal (REAL) is a Great Momentum Stock: Should You Buy?

Does The RealReal (REAL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Interparfums' Q3 Earnings Beat Estimates on Margin Expansion

IPAR beats Q3 2026 earnings and revenue estimates as gross margin expansion and tariff refunds lift profitability, prompting higher 2026 sales guidance.

How Much Upside is Left in The RealReal (REAL)? Wall Street Analysts Think 25.28%

The mean of analysts' price targets for The RealReal (REAL) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The RealReal Appoints Shar Dubey to Board of Directors

The RealReal Appoints Shar Dubey to Board of Directors The RealReal Appoints Shar Dubey to Board of DirectorsPR NewswireSAN FRANCISCO, Nov. 5, 2026 Former Match Group CEO Brings Deep Expertise in Technology, Digital Consumer Platforms and Scaling Global BusinessesSAN FRANCISCO, Nov. 5, 2026...

Reynolds' Q3 Earnings Beat Estimates as Pricing Offsets Inflation

REYN beat Q3 2026 earnings and revenue estimates as pricing offset inflation, but weaker retail volumes and higher expenses pressured margins.

SharkNinja, Inc. (SN) Hits Fresh High: Is There Still Room to Run?

SharkNinja, Inc. (SN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The RealReal (REAL) Tops Q3 Earnings and Revenue Estimates

The RealReal (REAL) delivered earnings and revenue surprises of +100.00% and +5.04%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, The RealReal (REAL) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for The RealReal (REAL) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

THE REALREAL ANNOUNCES THIRD QUARTER 2026 RESULTS

THE REALREAL ANNOUNCES THIRD QUARTER 2026 RESULTS THE REALREAL ANNOUNCES THIRD QUARTER 2026 RESULTSPR NewswireSAN FRANCISCO, Oct. 29, 2026 Third Quarter Delivers Record Revenue, GMV and Orders as Active Buyer Growth Accelerates and Margins Expand; Company Raises Full Year OutlookSAN FRANCISCO, Oct...

• Reported GAAP EPS of $0.02 up 150.00% YoY
• Reported revenue of $206.12M up 18.75% YoY

The RealReals take rate and direct revenue gross margin declined, while marketing and interest costs increased; its debt carries variable-rate exposure, and competition may pressure pricing and commissions.

The RealReal expanded consignment revenue, GMV, AOV, orders and active buyers, relied on repeat consignors for over 80% of GMV, and reported improved fulfillment efficiencies and higher total gross margin.

The RealReal, Inc. is an online marketplace for consigned luxury goods, which engages in the consignment of luxury goods across multiple categories, including women's, men's, kids, jewelry, watches, home, and art. It sells pieces from designers such as Chanel, Christian Louboutin, Gucci, Hermes, Louis Vuitton, Prada, Celine, Jimmy Choo, Burberry, and Valentino. The company was founded by Julie Wainwright and Marcy Carmack on March 29, 2011 and is headquartered in San Francisco, CA.

Therealreal Inc

RealReal Stock Rises On Q4 Revenue, GMV Performance: Retail Stays Extremely Bullish

Equity

Bearish Sentiment

Shares of the RealReal Inc. (REAL) rose 1.9% in after-hours trading Friday after the online marketplace for luxury goods posted a bump in its gross merchandise value and revenue for its fourth quarter, with retail staying optimistic.The company’s Q4 gross merchandise value (GMV) and total revenue increased 12% and 14%, respectively, compared to the year-ago period. Its full year 2024 GMV and total revenue increased 6% and 9% in the same period.For the latest quarter, loss per share stood at $0.01, narrower than the $0.04 expected by Wall Street analysts. While its revenue of $163.99 million beat estimates of $163.73 million.For its 2025 fiscal, it projected GMV between $1.96 and $1.99 billion. Revenue is projected between $645 and $660 million, compared to the consensus estimate of $655.98.Sentiment on Stocktwits remained in the ‘extremely bullish’ territory compared to a week ago. Message volume continued to be in the ‘extremely high’ zone.<figure class="image"><img style="aspect-ratio:1320/312;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_02_24_at_6_44_10_AM_b5f91b8a70.png" alt="Screenshot 2025-02-24 at 6.44.10 AM.png" width="1320" height="312"><figcaption>REAL sentiment meter and message volume on Feb 23</figcaption></figure> One commenter termed the stock as a “long-term” buy-and-hold.<stembedurl>https://stocktwits.com/ShortPress/message/605128611</stembedurl>“We achieved strong fourth quarter and full year 2024 results, exiting the year from a position of strength," said Rati Levesque, President and CEO of The RealReal. “We delivered on key milestones in 2024 including positive Adjusted EBITDA and positive free cash flow for the full year, and we are just getting started.”Levesque added the company is continuing its progress on strategic pillars, unlocking supply, and making efforts to drive operational efficiency. The company also sees significant opportunity to drive operating leverage and improve the consignor experience through enhanced use of AI.CFO Ajay Gopal added that the company’s recent strategic debt transaction has reduced its overall indebtedness.Following the earnings, Baird analyst Mark Altschwager raised the price target to $8.50 from $8 with a ‘Neutral’ rating, noting its Q4 results were in line and profitability is getting real, The Fly reported.RealReal stock is down 41% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image. Source: Getty Images

The company’s Q4 gross merchandise value and total revenue increased 12% and 14%, respectively.

Vanguard Total Stock Market ETF

Vanguard Extended Market ETF

SPDR S&P Retail ETF

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Feed

News

Sentiment

Earnings

Fundamentals

Info

REAL News